Dimethyl sulfoxide, meets analytical specification of Ch.P.
Dimethyl sulfoxide (DMSO), meets analytical specification of Ch.P. is an aprotic solvent that dissolves polar and non-polar compounds, including water-insoluble therapeutic and toxic agents. Dimethyl sulfoxide (DMSO) has a strong affinity for water and can rapidly penetrate or enhance the penetration of other substances into biological membranes. Dimethyl sulfoxide also has potential free radical scavenging and anticholinesterase effects and may affect coagulation activity. Dimethyl sulfoxide also induces histamine release from mast cells but is thought to have low systemic toxicity. Dimethyl sulfoxide also exhibits antifreeze and antibacterial properties[1][2][3].MCE provides Dimethyl sulfoxide that complies with the inspection standards (Ch.P) of Part 4 of the Chinese Pharmacopoeia (2020 Edition) . Amicrobic, low endotoxin, can be used in various biochemical experiments such as drug dissolution.
Product Specifications
CAS Number
[67-68-5]
Product Name Alternative
DMSO, meets analytical specification of Ch.P.
UNSPSC
12352200
Hazard Statement
H227, H315
Target
Bacterial; Cholinesterase (ChE)
Type
Biochemical Assay Reagents
Related Pathways
Anti-infection; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/dimethyl-sulfoxide.html
Purity
99.99
Smiles
O=S(C)C
Molecular Formula
C2H6OS
Molecular Weight
78.13
Precautions
H227, H315
References & Citations
[1]C F Brayton. Dimethyl sulfoxide (DMSO) : a review. Cornell Vet. 1986 Jan;76 (1) :61-90.|[2]William F Rawls, et al. Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: A review. Neurourol Urodyn. 2017 Sep;36 (7) :1677-1684.
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Citation 01
ACS Biomater Sci Eng. 2025 Sep 10.|ACS Chem Biol. 2025 Feb 21;20 (2) :464-478.|ACS Chem Neurosci. 2023 Mar 15;14 (6) :1071-1079.|ACS Nano. 2023 Nov 28;17 (22) :22334-22354.|ACS Nano. 2025 Apr 1;19 (12) :12382-12398.|ACS Nano. 2025 Sep 16;19 (36) :32306-32321.|ACS Omega. 2024 Dec 3;9 (50) :49739-49748.|ACS Omega. 2024 Jun 14;9 (26) :28228-28236.|Acta Cir Bras. 2025 Aug 18:40:e406825.|Acta Neuropathol Commun. 2025 Apr 25;13 (1) :84.|Acta Pharmacol Sin. 2025 Sep 10.|Adv Funct Mater. 2025 May 19.|Adv Healthc Mater. 2025 Mar 20:e2405124.|Adv Sci (Weinh) . 2023 Oct;10 (28) :e2302130.|Adv Sci (Weinh) . 2025 Aug 14:e09733.|Adv Sci (Weinh) . 2025 May 20:e2416489.|Am J Physiol Lung Cell Mol Physiol. 2025 Aug 1;329 (2) :L282-L295.|Animal Model Exp Med. 2025 Nov 11.|Animals (Basel) . 2024 Feb 9;14 (4) :585.|Ann Hematol. 2025 Feb;104 (2) :1165-1176.|Ann Rheum Dis. 2022 May;81 (5) :676-686.|Antioxid Redox Signal. 2025 Sep 29.|Antioxidants (Basel) . 2023 Mar 15;12 (3) :722.|Arch Dermatol Res. 2025 Mar 12;317 (1) :550.|Autophagy. 2023 Jun;19 (6) :1745-1763.|Autophagy. 2025 Aug 18:1-20.|Autophagy. 2025 Aug;21 (8) :1644-1661.|Biochem Biophys Res Commun. 2023 May 21:657:108-118.|Biochem Biophys Res Commun. 2024 May 25:723:150179.|Biochem Genet. 2025 Aug;63 (4) :3206-3219.|Biochem Genet. 2025 Jun;63 (3) :2743-2759.|Biochem Pharmacol. 2024 Jun 22:226:116389.|Biochem Pharmacol. 2024 Jun 27:116398.|Biochem Pharmacol. 2025 Apr 5:116922.|Biochem Pharmacol. 2025 Jul 12:241:117150.|Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Dec;1867 (12) :159217.|Biochim Biophys Acta Mol Cell Res. 2025 Jan 27:119911.|Biomark Res. 2023 Jan 24;11 (1) :8.|Biomed Pharmacother. 2023 Oct:166:115397.|Biomed Pharmacother. 2024 Apr:173:116425.|Biomed Pharmacother. 2024 Feb:171:116194.|Biomed Pharmacother. 2024 Nov:180:117485.|bioRxiv. 2024 Aug 6:2024.03.21.586169.|bioRxiv. 2024 Feb 1:2024.01.31.578278.|bioRxiv. 2024 Oct 7:2024.09.26.615278.|bioRxiv. 2025 April 09.|bioRxiv. 2025 January 25.|Biosci Biotechnol Biochem. 2023 Nov 21;87 (12) :1485-1494.|Biotechnol Genet Eng Rev. 2024 Nov;40 (3) :1407-1424.|Blood. 2016 Jun 23;127 (25) :3237-52.|BMC Biol. 2025 Feb 6;23 (1) :37.|BMC Med. 2023 Feb 21;21 (1) :68.|Bone Res. 2025 Jun 11;13 (1) :60.|Br J Pharmacol. 2025 Apr;182 (8) :1856-1875.|Br J Pharmacol. 2025 May 13.|Br J Pharmacol. 2025 Nov 7.|Brain Behav Immun. 2025 Oct 23:131:106148.|Brain Dev. 2025 Jul 1;47 (4) :104388.|Brain Res Bull. 2024 Jun 7:111004.|Cancer Cell Int. 2025 Nov 18;25 (1) :413.|Cancer Cell. 2025 Aug 12:S1535-6108 (25) 00330-7.|Cancer Chemother Pharmacol. 2024 Jan;93 (1) :41-54.|Cancer Commun (Lond) . 2024 Nov;44 (11) :1231-1260.|Cancer Commun (Lond) . 2025 Oct 16.|Cancer Res. 2025 Aug 27.|Cancers (Basel) . 2022 Oct 19;14 (20) :5127.|Cell Biochem Biophys. 2025 Mar;83 (1) :647-656.|Cell Biol Toxicol. 2025 Sep 2;41 (1) :129.|Cell Death Differ. 2025 Apr 9.|Cell Death Dis. 2025 May 21;16 (1) :407.|Cell Death Discov. 2024 May 29;10 (1) :263.|Cell Death Discov. 2025 Feb 5;11 (1) :47.|Cell Mol Biol Lett. 2025 Jul 28;30 (1) :93.|Cell Mol Life Sci. 2025 Nov 19;82 (1) :408.|Cell Prolif. 2024 May 29:e13678.|Cell Rep. 2023 Feb 28;42 (3) :112145.|Cell Rep. 2025 Mar 12;44 (3) :115400.|Cell Rep. 2025 Nov 25;44 (11) :116530.|Cell Stem Cell. 2024 Aug 21:S1934-5909 (24) 00285-6.|Cell Transplant. 2022 Jan-Dec:31:9636897221077921.|Cells. 2025 May 8;14 (10) :678.|Chem Biol Drug Des. 2023 Nov;102 (5) :1110-1120.|Chem Biol Drug Des. 2025 Feb;105 (2) :e70053.|Chem Biol Interact. 2024 Nov 1:403:111250.|Chem Biol Interact. 2025 May 3:111536.|Chem Eng J. 2025 Oct 15.|Chin Med J (Engl) . 2025 May 29.|Chin Med. 2023 Mar 31;18 (1) :34.|Clin Cancer Res. 2025 Jul 8.|Clin Epigenetics. 2023 Oct 17;15 (1) :163.|Clin Exp Hypertens. 2025 Dec;47 (1) :2486829.|Clin Exp Med. 2025 Jan 3;25 (1) :29.|Clin Immunol. 2023 Nov:256:109778.|Clin Med Insights Oncol. 2024 Apr 15:18:11795549241244783.|CNS Neurosci Ther. 2024 Jun;30 (6) :e14800.|CNS Neurosci Ther. 2025 Sep;31 (9) :e70609.|Commun Biol. 2025 Jul 29;8 (1) :1127.|Commun Biol. 2025 Jul 5;8 (1) :1009.|Commun Biol. 2025 Nov 23.|Connect Tissue Res. 2024 May 16:1-12.|Curr Biol. 2025 Apr 7;35 (7) :1612-1621.e3.|Dev Cell. 2025 Jul 21;60 (14) :1974-1990.e11.|Dev Cell. 2025 Jul 7;60 (13) :1854-1870.e6.|Drug Des Devel Ther. 2025 Mar 13:19:1909-1926.|Environ Health Perspect. 2023 Nov;131 (11) :117011.|Environ Pollut. 2025 May 7:126395.|Environ Sci Pollut Res Int. 2025 Apr;32 (16) :10490-10504.|Environ Sci Technol. 2025 May 6;59 (17) :8329-8344.|Eur J Histochem. 2023 Mar 20;67 (2) :3639.|Exp Cell Res. 2024 Aug 22;442 (1) :114218.|Exp Cell Res. 2024 May 24:114100.|Exp Eye Res. 2025 Oct:259:110509.|Exp Neurol. 2025 May 7:115303.|FEBS Lett. 2025 Feb;599 (3) :367-380.|Folia Histochem Cytobiol. 2025;63 (2) :79-87.|Food Sci Biotechnol. 2024 Feb 12;33 (11) :2585-2596.|Free Radic Biol Med. 2024 Feb 20:212:34-48.|Free Radic Biol Med. 2025 Aug 13:240:183-196.|Free Radic Biol Med. 2025 Nov 23:243:351-366.|Free Radic Biol Med. 2025 Nov:239:116-129.|Free Radic Biol Med. 2025 Sep:237:403-418.|Front Biosci (Landmark Ed) . 2024 Mar 15;29 (3) :106.|Front Cardiovasc Med. 2022 Jun 2;9:907747.|Front Pharmacol. 2022 Sep 16;13:976117.|Genes (Basel) . 2024 Sep 29;15 (10) :1278.|Heliyon. 2022 May 11;8 (5) :e09407.|Hematol Oncol. 2024 Sep;42 (5) :e3305.|Hereditas. 2025 Oct 21;162 (1) :216.|hLife. 2025 Jan 25.|Hum Exp Toxicol. Jan-Dec 2022;41:9603271221087146.|Inflamm Res. 2024 Nov;73 (11) :1981-1994.|Inflammopharmacology. 2024 Dec;32 (6) :3745-3759.|Int Immunopharmacol. 2022 Dec;113 (Pt A) :109340.|Int Immunopharmacol. 2022 Sep:110:109000.|Int Immunopharmacol. 2023 Jun:119:110204.|Int Immunopharmacol. 2023 Sep 24;124 (Pt B) :110956.|Int Immunopharmacol. 2024 Jun 24:138:112518.|Int Immunopharmacol. 2024 Sep 4;142 (Pt A) :113051.|Int Immunopharmacol. 2025 Apr 24:153:114401.|Int Immunopharmacol. 2025 Apr 4:151:114352.|Int Immunopharmacol. 2025 Jan 17:148:113972.|Int Immunopharmacol. 2025 Jan 18:148:114086.|Int Immunopharmacol. 2025 Jan 6:147:114022.|Int Immunopharmacol. 2025 Mar 29:154:114528.|Int Immunopharmacol. 2025 Sep 13:165:115485.|Int Immunopharmacol. 2026 Jan 1;168 (Pt 1) :115812.|Int J Biol Macromol. 2025 Dec;333 (Pt 2) :148750.|Int J Biol Macromol. 2025 May 7:144068.|Int J Biol Sci. 2024 Aug 19;20 (11) :4513-4531.|Int J Mol Med. 2024 May;53 (5) :49.|Int J Mol Sci. 2023 Aug 4;24 (15) :12448.|Int J Mol Sci. 2023 Jan 30;24 (3) :2586.|Int J Mol Sci. 2023 Jun 9;24 (12) :9954.|Int J Mol Sci. 2023 Mar 28;24 (7) :6327.|Int J Mol Sci. 2023 Sep 7;24 (18) :13812.|Int J Mol Sci. 2024 Jun 25;25 (13) :6947.|Int J Oncol. 2025 May;66 (5) :38.|iScience. 2023 May 9;26 (6) :106852.|iScience. 2023 Oct 5;26 (11) :108148.|iScience. 2024 Jan 18;27 (2) :108950.|iScience. 2024 Jan 20;27 (2) :108982.|iScience. 2024 Jun 28;27 (7) :110415.|iScience. 2024 May 5;27 (5) |J Adv Res. 2024 Nov 5:S2090-1232 (24) 00499-5.|J Adv Res. 2025 Sep 23:S2090-1232 (25) 00744-1.|J Am Heart Assoc. 2023 Jun 20;12 (12) :e029053.|J Biol Chem. 2024 Nov;300 (11) :107866.|J Cardiothorac Surg. 2023 Mar 24;18 (1) :92.|J Cell Biol. 2025 Oct 6;224 (10) :e202412224.|J Cell Mol Med. 2024 Nov;28 (22) :e70214.|J Cell Mol Med. 2025 Jul;29 (13) :e70692.|J Cell Mol Med. 2025 Mar;29 (5) :e70488.|J Chem Neuroanat. 2024 Mar:136:102375.|J Ethnopharmacol. 2023 Jan 30:301:115855.|J Ethnopharmacol. 2024 Apr 24:324:117759.|J Exp Clin Cancer Res. 2024 Dec 26;43 (1) :330.|J Exp Clin Cancer Res. 2025 Aug 29;44 (1) :260.|J Funct Foods. 2023 Mar.|J Funct Foods. 2024 Oct.|J Inflamm (Lond) . 2024 Aug 28;21 (1) :32.|J Mol Histol. 2025 Aug 8;56 (4) :259.|J Mol Neurosci. 2022 Oct;72 (10) :2125-2135.|J Nanobiotechnology. 2024 Sep 3;22 (1) :532.|J Neuroinflammation. 2022 Dec 22;19 (1) :310.|J Neuroinflammation. 2024 Nov 14;21 (1) :295.|J Oncol. 2022 Dec 29:2022:3658334.|J Orthop Translat. 2023 Jan 25:39:74-87.|J Orthop Translat. 2024 Aug 8:48:133-145.|J Pathol. 2025 Aug;266 (4-5) :465-480.|J Pharm Pharmacol. 2025 Jun 6:rgaf040.|J Radiat Res. 2023 Jan 20;64 (1) :63-72.|J Transl Med. 2024 Nov 20;22 (1) :1047.|J Transl Med. 2025 Aug 19;23 (1) :939.|J Virol. 2025 Sep 8:e0086825.|J Water Process Eng. 2025 Sep.|JOR Spine. 2024 Apr 17;7 (2) :e1325.|Kaohsiung J Med Sci. 2022 Apr;38 (4) :367-377.|Life Sci. 2023 Mar 15:317:121439.|Life Sci. 2023 Sep 15:329:121968.|Life Sci. 2025 Jan 17:363:123402.|Life Sci. 2025 May 21:123753.|Liver Int. 2022 Dec;42 (12) :2889-2899.|Liver Int. 2024 Mar;44 (3) :691-705.|Mater Today Bio. 2025 Oct 1:35:102359.|mBio. 2024 Feb 14;15 (2) :e0319723.|mBio. 2025 Aug 13;16 (8) :e0097625.|Mediators Inflamm. 2024 Jan 30:2024:8828367.|Mediators Inflamm. 2024 Oct 18:2024:9550301.|Mol Biol Rep. 2024 Mar 27;51 (1) :453.|Mol Cancer. 2025 Mar 26;24 (1) :97.|Mol Hum Reprod. 2025 Jun 10:gaaf027.|Mol Immunol. 2024 Dec 25:177:73-84.|Mol Med. 2022 Nov 26;28 (1) :141.|Mol Med. 2023 Mar 1;29 (1) :30.|Mol Med. 2024 Dec 19;30 (1) :245.|Mol Med. 2024 Nov 27;30 (1) :235.|Mol Neurobiol. 2024 May;61 (5) :2949-2963.|Mol Neurobiol. 2025 May 22.|Mol Psychiatry. 2025 Aug 6.|Mol Ther. 2025 Jan 8;33 (1) :279-296.|Molecules. 2024 Nov 21;29 (23) :5491.|Mutat Res. 2024 Aug 10:829:111877.|Nat Commun. 2023 Dec 1;14 (1) :7940.|Nat Commun. 2024 Dec 3;15 (1) :10536.|Nat Commun. 2025 Jan 3;16 (1) :289.|Nat Immunol. 2024 Aug;25 (8) :1422-1431.|Nat Neurosci. 2025 Nov 24.|Nat Protoc. 2022 May;17 (5) :1266-1305.|Nature. 2024 Aug;632 (8025) :686-694.|Neuropharmacology. 2025 Oct 28:283:110752.|Neuropsychiatr Dis Treat. 2022 May 16:18:1027-1037.|Oncol Rep. 2022 Oct;48 (4) :169.|Oncol Res. 2024 Jul 17;32 (8) :1359-1368.|OpenNano. 2023 May 6, 100160.|Part Sci Technol. 2025 Jul 03.|Patent. US20240369511A1.|Pestic Biochem Physiol. 2023 Dec:197:105647.|Pharmaceutics. 2024 Aug 27;16 (9) :1130.|Phytomedicine. 2023 May:113:154725.|Phytomedicine. 2024 Jan:122:155079.|Phytomedicine. 2024 Nov 14:136:156227.|Phytomedicine. 2025 Jun:141:156697.|Phytomedicine. 2025 Nov 22:150:157584.|Phytomedicine. 2025 Oct 8:148:157389.|Proc Natl Acad Sci U S A. 2024 Nov 26;121 (48) :e2406961121.|Protein Expr Purif. 2025 Sep 26:106824.|Rejuvenation Res. 2025 Sep 18.|Reprod Domest Anim. 2024 Nov;59 (11) :e14746.|Res Sq. 2024 Aug 29.|Res Sq. 2024 Jun 26.|Res Sq. 2024 Nov 10.|Research Square Preprint. 2022 Feb.|Research Square Preprint. 2023 Nov 8.|Research Square Preprint. 2024 Oct 13.|Research Square Print. 2022 Aug.|Research Square Print. 2023 Feb 1.|Research Square Print. 2023 Mar 23.|Research Square Print. November 18th, 2022|Sci Adv. 2024 Sep 6.|Sci Rep. 2024 Dec 5;14 (1) :30402.|Sci Rep. 2024 Nov 16;14 (1) :28327.|Sci Rep. 2025 Jan 24;15 (1) :3124.|Sci Rep. 2025 Jul 1;15 (1) :22327.|Sci Rep. 2025 Jul 11;15 (1) :25045.|Sci Total Environ. 2024 Feb 20:912:168949.|Sex Med. 2025 Aug 6;13 (4) :qfaf059.|Signal Transduct Target Ther. 2023 Sep 25;8 (1) :366.|Signal Transduct Target Ther. 2025 Oct 14;10 (1) :341.|SSRN. 2025 Jun 5.|Structure. 2022 Aug 4;30 (8) :1190-1207.e5.|Technol Cancer Res Treat. Jan-Dec 2022;21:15330338221085361.|Theranostics. 2025 Mar 21;15 (10) :4593-4613.|Tissue Cell. 2025 Aug 14:97:103089.|Toxicol Appl Pharmacol. 2024 Feb:483:116836.|Toxicol In Vitro. 2023 Sep:91:105626.|Toxicol Res. 2025 Sep 1.|Toxicology. 2024 Aug 13:153923.|Toxicology. 2025 Jun:514:154117.|Toxics. 2025 Apr 23;13 (5) :332.|Transl Cancer Res. 2025 Oct 31;14 (10) :6637-6652.|Transplantation. 2022 Nov 1;106 (11) :2172-2181.|University of Sheffield. 2024 Nov 05.|Vascular. 2024 Aug 18:17085381241273289.|Vet Microbiol. 2025 Sep:308:110658.|Virol Sin. 2025 Aug;40 (4) :647-657.|Virology. 2023 Oct:587:109877.|Water Biol Secur. 2025 Sep 18.|Cell Rep. 2025 Jul 23;44 (8) :116018.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
